<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.org news tagged with: chronic liver disease</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New data show non-alcoholic fatty liver disease will reach epidemic status in the US</title>
   	 <description>According to new data presented today at the International Liver Congress, the United States (U.S.) could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease (NAFLD)1, one of the major contributing factors of chronic liver disease (CLD), considered as one of the major causes of morbidity and mortality worldwide. The study highlights that if the current rates of obesity and diabetes continue for another two decades, the prevalence of NAFLD in the US is expected to increase by 50% in 2030.</description>
     <link>http://phys.org/news220938201.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 02 Apr 2011 04:44:42 EST</pubDate>
	 <guid isPermaLink="false">news220938201</guid>
	 
</item>
<item>
     <title>Seroprevalence of anti-HAV among patients with chronic viral liver disease</title>
   	 <description>A research team from South Korea investigated the current seroprevalence of hepatitis A virus (HAV) antibodies in patients with chronic viral liver disease in Korea. They found that most Korean patients with chronic liver disease and who are above 40 years of age have already been exposed to HAV.</description>
     <link>http://phys.org/news215176172.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 25 Jan 2011 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news215176172</guid>
	 
</item>
<item>
     <title>First Irish genome sequenced</title>
   	 <description>The first entire genome of an Irish individual has been sequenced. The sequence is reported in BioMed Central's open access journal, Genome Biology and provides insight into the evolutionary history of this distinct lineage.</description>
     <link>http://phys.org/news203076474.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 07 Sep 2010 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news203076474</guid>
	 
</item>
<item>
     <title>Alcoholic liver disease is more aggressive than other chronic liver diseases</title>
   	 <description>Many diagnostic and treatment options have been developed for chronic liver disease during the last 40 years, yet their influence on survival remain unclear.  A new study of the prognosis for patients hospitalized for liver diseases between 1969 and 2006, and of differences in mortality and complications between patients with alcoholic and non-alcoholic liver diseases, has found that the general prognosis for patients hospitalized with chronic liver diseases has not improved.</description>
     <link>http://phys.org/news201886426.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 24 Aug 2010 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news201886426</guid>
	 
</item>
<item>
     <title>Chinese vaccine shields against hepatitis E - Lancet</title>
   	 <description> A prototype vaccine devised and tested in China has proven 100-percent effective in preventing hepatitis E, a disease that is widespread in the developing world and can be fatal, investigators reported in The Lancet on Monday.</description>
     <link>http://phys.org/news201761356.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Aug 2010 05:49:29 EST</pubDate>
	 <guid isPermaLink="false">news201761356</guid>
	 
</item>
<item>
     <title>Mayo Clinic Proceedings: Review of pain management practices for cirrhosis patients</title>
   	 <description>In the May issue of Mayo Clinic Proceedings, physician experts review current practices for pain management in cirrhotic patients. The physician experts reviewed all current literature available on PubMed and MEDLINE with no limits in the search to recommend a uniform and practical guide to approaching analgesia in the cirrhotic patients.</description>
     <link>http://phys.org/news194101312.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 26 May 2010 14:40:02 EST</pubDate>
	 <guid isPermaLink="false">news194101312</guid>
	 
</item>
<item>
     <title>Fatal assaults 30 times higher among poor Scots than among most affluent</title>
   	 <description>Fatal assaults among the most disadvantaged in Scotland are more than 30 times as high as they are among the most affluent sectors of society, reveals research published today in the Journal of Epidemiology and Community Health.</description>
     <link>http://phys.org/news192305404.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 05 May 2010 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news192305404</guid>
	 
</item>
<item>
     <title>Study shows liver transplant center impacts patient outcomes</title>
   	 <description>For patients in need of a liver transplant, their choice of a transplant center can make a noteworthy difference in their outcomes, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.</description>
     <link>http://phys.org/news192083460.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 May 2010 06:40:02 EST</pubDate>
	 <guid isPermaLink="false">news192083460</guid>
	 
</item>
<item>
     <title>NIH study offers hope to patients with nonalcoholic steatohepatitis</title>
   	 <description>A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis (NASH), according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. Results were published April 28 online in the New England Journal of Medicine. In addition,  Actos (pioglitazone), a drug used to treat diabetes, also improved many features of NASH but was associated with weight gain.</description>
     <link>http://phys.org/news191694233.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 28 Apr 2010 17:50:01 EST</pubDate>
	 <guid isPermaLink="false">news191694233</guid>
	 
</item>
<item>
     <title>New Biomarker Could Lead To The World's First Reliable Test For Liver Cancer</title>
   	 <description>(PhysOrg.com) -- Liver cancer is the fifth most common cancer in the world and one of the deadliest cancers since it is rarely diagnosed until late in its development.</description>
     <link>http://phys.org/news190042719.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 09 Apr 2010 14:50:01 EST</pubDate>
	 <guid isPermaLink="false">news190042719</guid>
	 
</item>
<item>
     <title>Donor kidneys from Hepatitis C patients needlessly denied to patients with that infection</title>
   	 <description>More than half of donor kidneys in the United State infected with hepatitis C are thrown away, despite the need among hepatitis C patients who may die waiting for an infection-free organ, Johns Hopkins research suggests.</description>
     <link>http://phys.org/news189340791.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 01 Apr 2010 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news189340791</guid>
	 
</item>
<item>
     <title>Common test for detecting liver problems in children is often interpreted incorrectly</title>
   	 <description>New research led by physician-scientists at University of California, San Diego School of Medicine shows that the test most commonly used to screen pediatric patients for chronic liver disease is often incorrectly interpreted in many children's hospitals throughout the United States.</description>
     <link>http://phys.org/news189335391.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 01 Apr 2010 10:20:02 EST</pubDate>
	 <guid isPermaLink="false">news189335391</guid>
	 
</item>
<item>
     <title>Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis</title>
   	 <description>Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis.  Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents.   Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models.  Details of this study are published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://phys.org/news186584760.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Mar 2010 00:00:05 EST</pubDate>
	 <guid isPermaLink="false">news186584760</guid>
	 
</item>
<item>
     <title>A high fat diet during pregnancy can lead to severe liver disease in offspring</title>
   	 <description>Scientists have discovered a previously unknown link between a mother's diet in pregnancy and a severe form of liver disease in her child.</description>
     <link>http://phys.org/news174661978.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 13 Oct 2009 14:14:02 EST</pubDate>
	 <guid isPermaLink="false">news174661978</guid>
	 
</item>
<item>
     <title>Researchers find high-dose therapy for liver disease not effective</title>
   	 <description>A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.</description>
     <link>http://phys.org/news170682180.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 28 Aug 2009 12:43:47 EST</pubDate>
	 <guid isPermaLink="false">news170682180</guid>
	 
</item>
<item>
     <title>Metabolic bone disease in cirrhosis patients</title>
   	 <description>Long-standing liver disease has long been recognized to result in fragile bones with increased risk of fractures. In various international studies, the overall incidence has varied from 11% to 48%, with a fracture rate of 3%-44%. However, the reason for this is poorly understood. With liver transplantation becoming a viable option in liver disease and offering complete cure and long-term survival, bone disease is becoming the major determinant of survival and quality of life in these patients.</description>
     <link>http://phys.org/news169120686.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news169120686</guid>
	 
</item>
<item>
     <title>Probe position may change results in liver stiffness measurements in transient elastography</title>
   	 <description>A major clinical challenge is to find the best method to evaluate and to manage the increasing numbers of patients with chronic liver disease. Liver biopsy, due to its risks and limitations, is no longer considered mandatory as the first-line indicator of liver injury, and several markers have been developed as non-invasive alternatives.</description>
     <link>http://phys.org/news168086414.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Jul 2009 11:40:32 EST</pubDate>
	 <guid isPermaLink="false">news168086414</guid>
	 
</item>


</channel>
</rss>
